title: [Comprehensive treatment of stage-lllb testicular non-seminomatous germ cell tumor: a case report and review of the literature].
abstract: OBJECTIVE
  To investigate the comprehensive treatment of stage-IIIb testicular non-seminomatous germ cell tumor (NSGCT) based on the chemotherapy with cisplatin, etoposide and bleomycin (BEP) and nerve-sparing laparoscopic retroperitoneal lymph node dissection (nsLRPLND).
  
  
  METHODS
  We reported a case of stage-IIIb testicular NSGCT, analyzed the clinical data and treatment methods and reviewed the relevant literature.
  
  
  RESULTS
  The patient underwent chemotherapy with etoposide (0. 18 g/d for the first 3 days), cisplatin (30 mg/d for the first 5 days), and bleomycin (30 mg/d on day 2, 9 and 16) for 3 cycles, followed by nsLRPLND. Both chemotherapy and surgery were successfully performed. The operation time was 175 min, with intraoperative blood loss of 50 ml, but no severe perioperative complications. No recurrence and distant metastasis were found during the 6-month follow-up after surgery.
  
  
  CONCLUSIONS
  The comprehensive treatment based on BEP chemotherapy and nsRPLND can be used as an option for stage-IIIb testicular NSGCT.
authors.forename: Jin-Bo
authors.initials: JB
authors.lastname: Chen
authors.forename: Xiong-Bing
authors.initials: XB
authors.lastname: Zu
authors.forename: Lin
authors.initials: L
authors.lastname: Qi
authors.forename: Min-Feng
authors.initials: MF
authors.lastname: Chen
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D006801:Humans; D008197:Lymph Node Excision / Q000379:methods; D008297:Male; D012189:Retrospective Studies; D013736:Testicular Neoplasms / Q000628:therapy*